Anavex Life Sciences Corp (AVXL)

[falconer66a]

The arcane and inscrutable investment machinations of hedge funds, “financial advisors” and the like are far beyond anything I know.

How come far more astute investment advisors fail to see what I see in the Anavex data? Well, they aren’t ignorant. Most of them had an elementary statistics course in their MBA or other training. The precise Anavex data are not a mystery to them — the data, perhaps, are a threat, jeopardizing self-serving positions they have or wish to take regarding Big Pharma investments.

I’ll let others speculate on all of that. That’s why I indicated “retail Anavex investors.” We common citizen owners of Anavex shares, with long positions, have parsed the available data and are very comfortable with our positions. We won’t be selling anytime soon. We can see that the Anavex story will develop over years, not months; and has the potential to change 21st-century medicine even more than antibiotics did in the last century.

Efficacious treatment of Central Nervous System diseases, as with (soon enough) Alzheimer’s and Rett Syndrome, alone will be transformative. I take a longer view, where Anavex technologies will be used for geriatric disease prophylaxis. That’s a big, long story too detailed to describe here. Later.